A recent study indicates that dopamine transporter imaging could be valuable in monitoring Parkinson’s disease progression by tracking motor symptom deterioration over time. The decline in dopamine transporter signal in the less affected putamen is associated with worsening motor function, offering an objective method to monitor disease progression and potentially guide personalized monitoring and treatment strategies.

Source: Annals of Neurology